We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.
Find University Hospitals Doctors
Kevin Makino, MD, PhD

Kevin Makino, MD, PhD

  • Specialty: Psychiatry-Child and Adolescent Psychiatry, Psychiatry
    View Expertise
  • Primary Location: 10524 Euclid Ave (0 mi.)
    Other Locations
  • Languages Spoken: English

Office Locations

UH W.O. Walker Center (0 mi.)

10524 Euclid Ave
1st Floor Ste 1155A
Cleveland, OH 44106
216-844-3881

UH Rainbow Babies & Children's Hospital (0 mi.)

11100 Euclid Ave
Ste 170
Cleveland, OH 44106
216-844-7770

Biography: Kevin Makino, MD, PhD

Expertise

  • Attention Deficit Disorder (ADD)
  • Attention Deficit Hyperactivity Disorder (ADHD)
  • Collaborative Mental Health
  • LGBTQ and Mental Health
  • Pediatric Anxiety Disorders
  • Pediatric Gender Care
  • Pediatric Mood Disorders
  • Pediatric Trauma-Related Disorders

Titles

  • Associate Program Director, Post Pediatric Portal, UH Cleveland Medical Center

Certifications & Memberships

  • Child and Adolescent Psychiatry - American Board of Psychiatry and Neurology
  • Psychiatry - American Board of Psychiatry and Neurology
  • Pediatrics - American Board of Pediatrics

Education

Fellowship | Child and Adolescent Psychiatry
Child and Adolescent Psychiatry - UH Cleveland Medical Center (2019 - 2022)

Residency | Pediatrics
Pediatrics - Kapiolani Medical Center For Women And Children (2016 - 2019)

Medical Education
University Of Rochester School Of Medicine And Dentistry (2016)

Other Education
University Of Rochester School Of Medicine And Dentistry (2014)

Undergraduate
Oberlin College (1999)

Industry Relationships

University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.

UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.

View UH’s policy (PDF) on practitioner-industry relationships.

As of December 31, 2016, Kevin Makino did not disclose any Outside Relationships with Industry.